Company: NDRA
Filing Date: 2025-10-17
Form Type: PRE 14A
Source: 0001654954-25-011931
Chunk: 38

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-17
Form: PRE 14A
Chunk 38
---
 Fair Value of Equity Awards Granted and  Vested During the Applicable Subject Year | - |     | Plus/ (Less): Year-Over-Year Change in Fair Value of Outstanding and Unvested Equity Awards at Year End Granted in Prior Years | (37,785 | ) |     | Plus/ (Less): Change in Value of Equity Awards Granted in Prior Years and Vested During the Applicable Subject Year | (12,282 | ) |     | Less: Fair Value at the End of the Prior Year of Equity Awards Forfeited During the Applicable Subject Year | - |     | Plus: Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Fair Value or Total Compensation in the Summary Compensation Table for the Applicable Subject Year | - |     | Total Adjusted Equity Value | (50,067  | ) |
|:-----|:----|:------------------------------------------------------------------------|:---------|:--|:----|:---------------------------------------------------------------------------------------------------------------|-------:|:----|:------------------------------------------------------------------------------------------------------|:--|:----|:-------------------------------------------------------------------------------------------------------------------------------|:--------|:--|:----|:--------------------------------------------------------------------------------------------------------------------|:--------|:--|:----|:------------------------------------------------------------------------------------------------------------|:--|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--|:----|:----------------------------|:---------|:--|
| 2023 |     |                                                                         | (141,229 | ) |     |                                                                                                                | 68,890 |     |                                                                                                       | - |     |                                                                                                                                | (24,638 | ) |     |                                                                                                                     | (10,035 | ) |     |                                                                                                             | - |     |                                                                                                                                                                                       | - |     |                             | (107,011 | ) |
| 2022 |     |                                                                         | (131,855 | ) |     |                                                                                                                | 77,106 |     |                                                                                                       | - |     |                                                                                                                                | (11,636 | ) |     |                                                                                                                     | (49,115 | ) |     |                                                                                                             | - |     |                                                                                                                                                                                       | - |     |                             | (115,499 | ) |

| (5) | The values disclosed in this TSR column represent the measurement period value of an investment of $100 in the Company's shares as of December 31, 2021, and then valued again on each of December 31, 2022, 2023, and 2024. |
| (6) | The dollar amounts reported represent the amount